HAVN Life Sciences Inc.
HAVN
Rang in aandelen
#38577
HAVN Life Sciences Inc. is a biotechnology firm dedicated to the research and... HAVN Life Sciences Inc. is a biotechnology firm dedicated to the research and creation of psychotropic compounds sourced from flora and fungi. The company's expertise includes devising standardized and quality-assured extraction techniques for psychoactive substances, particularly from Psilocybe mushrooms, to isolate key compounds such as psilocybin, psilocin, and baeocystin. Furthermore, it develops natural health remedies using non-regulated ingredients. This Canadian company, founded in 2020, is headquartered in Richmond.
Aandeelprijs
$0.02201811
Laatst gesynchroniseerd: 2024-07-23
Marktkapitalisatie
$847.02K
Verandering (1 dag)
-0.22%
Verandering (1 jaar)
21,918.11%
Land
CA
Handel HAVN Life Sciences Inc. (HAVN)
Categorie
Healthcare
Koersgeschiedenis voor HAVN Life Sciences Inc. (HAVN)
Hoogste slotkoers: $0.00 op 2026-10-01
Laagste slotkoers: $20.74 op 2020-10-01
Laagste slotkoers: $20.74 op 2020-10-01
Koersgeschiedenis van HAVN Life Sciences Inc. van 2020 tot 2026
Jaarlijkse koersprestatie
| Jaar | Prestaties |
|---|---|
| 2026 (TTM) | 0.00% |
| 2025 | -78.42% |
| 2024 | -84.57% |
| 2023 | -46.81% |
| 2022 | -98.79% |
| 2021 | -81.70% |
| 2020 | 0.00% |
Aandelenkoers van vergelijkbare bedrijven of concurrenten
| Bedrijf | Aandelenkoers | Verandering 1jr% | Land |
|---|---|---|---|
| $534.12 | 25.25% |
US
|
|
| $231.12 | 760.78% |
US
|
|
| $137.83 | -3.78% |
AU
|
|
| $880.75 | 8.18% |
NL
|
|
| $289.51 | 1.72% |
BE
|
